Biotech Values

[iwfal]

GERN and yet another way to differentiate your interpretation from mine, JQ's, pgs etc..

I predict that there will be many fewer patients with Non-palpable spleen and liver than there are "CRs and PRs". But if you were correct there would have to be AT LEAST AS MANY patients with non palpable liver and spleen as there are CRs and PRs.

The point here is that in a full data release it will be easy to tell. If you were correct the clinical response would be very high.